Capital Fund Management (CFM)
PRAX icon

Capital Fund Management (CFM)’s Praxis Precision Medicines PRAX Stock Holding History

Capital Fund Management (CFM)’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,292
Closed -$1.02M – 2639
2025
Q2 		$1.02M Buy
+24,292
New +$925K ﹤0.01% 1995

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Capital Fund Management (CFM)'s PRAX Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of Praxis Precision Medicines (PRAX) in Q3 2025, closing a stake of 24,292 shares — an estimated $1.02M sold.

Capital Fund Management (CFM) first reported a position in PRAX in Q2 2025 and held it in 1 quarter. The position peaked at $1.02M in Q2 2025. 152 funds tracked by Wall St. Rank hold PRAX as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining Praxis Precision Medicines position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 24,292 Praxis Precision Medicines shares in Q3 2025, an estimated $1.02M.
  • Capital Fund Management (CFM) first reported a position in Praxis Precision Medicines in Q2 2025 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s Praxis Precision Medicines position peaked at $1.02M in Q2 2025.
  • 152 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.